These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series. Esposito M; Mazzotta A; Casciello C; Chimenti S Dermatology; 2008; 216(4):355-60. PubMed ID: 18285687 [TBL] [Abstract][Full Text] [Related]
3. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept. Vine K; Votava HJ; Smith BL Cutis; 2012 Sep; 90(3):132-6. PubMed ID: 23094312 [TBL] [Abstract][Full Text] [Related]
4. Etanercept for psoriasis in the pediatric population: experience in nine patients. Hawrot AC; Metry DW; Theos AJ; Levy ML Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417 [TBL] [Abstract][Full Text] [Related]
5. Recalcitrant palmoplantar pustular psoriasis treated with etanercept. Floristan U; Feltes R; Ramírez P; Alonso ML; De Lucas R Pediatr Dermatol; 2011; 28(3):349-50. PubMed ID: 21371112 [TBL] [Abstract][Full Text] [Related]
6. Etanercept for the treatment of psoriasis. Bissonnette R Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060 [TBL] [Abstract][Full Text] [Related]
7. Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence. Foley PA; Quirk C; Sullivan JR; Dolianitis C; Hack SP; Thirunavukkarasu K; Cooper AJ J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1135-43. PubMed ID: 20337816 [TBL] [Abstract][Full Text] [Related]
8. Etanercept in psoriasis treatment. Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989 [TBL] [Abstract][Full Text] [Related]
9. Refractory erythrodermic psoriasis in a child with an excellent outcome by using etanercept. Fraga NA; Paim Mde F; Follador I; Ramos AN; Rêgo VR An Bras Dermatol; 2011; 86(4 Suppl 1):S144-7. PubMed ID: 22068796 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies. Vena GA; Cassano N; Piaserico S; Conti A; Girolomoni G Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):901-6. PubMed ID: 22686544 [TBL] [Abstract][Full Text] [Related]
11. Etanercept combined with methotrexate for high-need psoriasis. Driessen RJ; van de Kerkhof PC; de Jong EM Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310 [TBL] [Abstract][Full Text] [Related]
12. Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept. Kamarashev J; Lor P; Forster A; Heinzerling L; Burg G; Nestle FO Dermatology; 2002; 205(2):213-6. PubMed ID: 12218252 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of von Zumbusch generalized pustular psoriasis with cyclosporine after eruption post etanercept injection. Ephrem G; Jour G; Smith BL J Med Liban; 2011; 59(3):168-9. PubMed ID: 22259908 [TBL] [Abstract][Full Text] [Related]
14. Etanercept for psoriasis: two case reports. Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631 [TBL] [Abstract][Full Text] [Related]
15. [Episode of pustular psoriasis after a tuberculin test in a patient with plaque psoriasis on treatment with etanercept]. Guinovart RM; Ferrándiz C; Bielsa I; Carrascosa JM Actas Dermosifiliogr; 2011 Dec; 102(10):828-30. PubMed ID: 21798486 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis. Uhlenhake EE; Feldman SR Expert Opin Biol Ther; 2010 Jul; 10(7):1105-12. PubMed ID: 20446825 [TBL] [Abstract][Full Text] [Related]
17. Etanercept for the treatment of psoriasis: combination therapy with other modalities. Strober BE; Clarke S J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161 [TBL] [Abstract][Full Text] [Related]
18. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma. Chong BF; Wong HK Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508 [TBL] [Abstract][Full Text] [Related]
19. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502 [TBL] [Abstract][Full Text] [Related]
20. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept. Di Nuzzo S; Zanni M; De Panfilis G J Drugs Dermatol; 2007 Oct; 6(10):1046-7. PubMed ID: 17966184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]